Carisma Therapeutics, Inc. (CARM)
OTCMKTS · Delayed Price · Currency is USD
0.0002
-0.0003 (-60.00%)
At close: Oct 19, 2026
Carisma Therapeutics Market Cap
Carisma Therapeutics has a market cap or net worth of $8.37 thousand as of October 20, 2026. It is the 51,867th most valuable company in the world and the 7,883rd biggest in the United States. Its market cap has decreased by 99.45% in one year.
Market Cap
8.37K
Enterprise Value
-2.01M
Revenue
52.63M
Global Rank
Country Rank
#7,883 United States
PE Ratio
0.00
ChartMarket Cap Chart
Since March 8, 2023, Carisma Therapeutics's market cap has decreased from 147.73M to 8.37K, a decrease of -99.99%. That is a compound annual growth rate of -93.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 8.37K | -99.53% |
| Dec 31, 2025 | 1.80M | -89.71% |
| Dec 31, 2024 | 17.48M | -85.21% |
| Dec 29, 2023 | 118.25M | -19.96% |
| Mar 8, 2023 | 147.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nascent Biotech | 34.57K |
| Burzynski Research Institute | 26.29K |
| Biostax | 21.65K |
| Health Sciences Group | 20.51K |
| Scopus BioPharma | 16.83K |
| Anebulo Pharmaceuticals | 16.31K |
| Bio-Path Holdings | 16.17K |
| Vaxxinity | 12.68K |